Phathom Pharmaceuticals, Inc.PHATNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank43
3Y CAGR-42.4%
Studio
Year-over-Year Change

Return on equity

3Y CAGR
-42.4%/yr
vs +27.5%/yr prior
Acceleration
-69.9pp
Decelerating
Percentile
P43
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
202550.49%-61.7%
2024131.84%-52.4%
2023277.07%+4.8%
2022264.29%+232.5%
2021-199.41%-200.1%
2020-66.44%+27.8%
2019-92.01%-191.9%
2018100.16%-